Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Euronext Paris  >  Orpéa    ORP   FR0000184798

ORPÉA (ORP)
Mes dernières consult.
Most popular
  Report  
Delayed Quote. Delayed  - 07/13 05:35:01 pm
121.85 EUR   +0.08%
07/13ORPÉA : Ex-dividend day for final dividend
FA
05/02ORPEA : Strong growth of 10.7% in Q1 2018 revenue to €832m
PU
05/02ORPÉA : 1st quarter earnings
CO
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Euronext Paris
07/09/2018 07/10/2018 07/11/2018 07/12/2018 07/13/2018 Date
117.45(c) 118.6(c) 121(c) 122.85(c) 121.85(c) Last
84 529 74 031 121 790 107 471 92 971 Volume
-0.21% +0.98% +2.02% +1.53% -0.81% Change
More quotes
Financials (EUR)
Sales 2018 3 401 M
EBIT 2018 447 M
Net income 2018 227 M
Debt 2018 4 363 M
Yield 2018 0,98%
Sales 2019 3 618 M
EBIT 2019 485 M
Net income 2019 255 M
Debt 2019 4 322 M
Yield 2019 1,10%
P/E ratio 2018 33,45
P/E ratio 2019 29,27
EV / Sales2018 3,60x
EV / Sales2019 3,37x
Capitalization 7 870 M
More Financials
Company
Orpea SA engages in the operation of geriatric healthcare facilities.Its services include nursing home, retirement homes, post acute, follow-up care clinics, rehabilitation, and psychiatric care clinics.The company was founded by Jean-Claude Marian in 1989 and is headquartered in Paris, France. 
More about the company
Surperformance© ratings of Orpéa
Trading Rating : Investor Rating :
More Ratings
Latest news on ORPÉA
07/13ORPÉA : Ex-dividend day for final dividend
FA
05/25ORPEA : RDIF, CDC IC and Orpea Sign an Agreement on Cooperation in Medical Rehab..
AQ
05/02ORPEA : Strong growth of 10.7% in Q1 2018 revenue to €832m
PU
05/02ORPÉA : 1st quarter earnings
CO
04/05ORPEA SA : Post Stabilisation Notice
GL
03/27ORPÉA : Annual results
CO
03/01ORPEA SA : Pre Stabilisation Notice
GL
02/28ORPÉA : Slide show results
CO
2017ORPEA : Strong Q3 2017 revenue growth
PU
2017ORPEA : Early redemption of the ORNANE 2020 bond completed successfully
PU
More news
Sector news : Residential & Long Term Care
07/13Fresenius SE Had Testing Issues Like Akorn's, Executive Says -Bloomberg
DJ
07/13Fortis Healthcare's Board Approves IHH Healthcare's Takeover Offer -- Update
DJ
07/13Fortis Healthcare's Board Approves IHH Healthcare's Takeover Offer
DJ
07/02New salvo from activist investor turns up heat on Nestle
RE
07/02New salvo from activist investor turns up heat on Nestle
RE
More sector news : Residential & Long Term Care
4-Traders Strategies on ORPÉA 
ORPÉA - 2017
In an accumulation phase
BUY
ORPÉA - 2017
Good timing to anticipate a continuation of the trend
BUY
More Strategies
Latest Tweets
06/21$ORP S.A. Orpea | BUY, EUR125 | A growth story difficult to question: The wo.. 
05/02Orpea ACT reports Q1 results  
05/02ORPEA: Strong Growth Of 10.7% In Q1 2018 Revenue To €832M  
04/05$ORP Orpea- 2H17 - Strong sales dynamics; lower real estate spending should .. 
04/04ORPEA W 100S 1806 SOC : Titre  
More tweets
Qtime:36
News from SeekingAlpha
05/02Orpea ACT reports Q1 results 
03/27Orpea ACT reports FY results 
2017Orpea ACT reports Q3 results 
2017Orpea ACT reports Q2 results 
2017Alzheimer's Is China's Biggest Future Health Problem - And Biggest Healthcare.. 
Chart ORPÉA
Duration : Period :
Orpéa Technical Analysis Chart | ORP | FR0000184798 | 4-Traders
Technical analysis trends ORPÉA
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 11
Average target price 118 €
Spread / Average Target -3,2%
EPS Revisions
Managers
NameTitle
Yves Le Masne Chief Executive Officer & Director
Philippe Charrier Chairman
Jean-Claude Brdenk Chief Operating Officer
Jean-Patrick Fortlacroix Independent Director
Thierry Mabille de Poncheville Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
ORPÉA23.96%9 195
BROOKDALE SENIOR LIVING, INC.-2.16%1 780
CIVITAS SOLUTIONS INC-4.39%590
CARETECH HOLDINGS PLC-11.98%379
JAPARA HEALTHCARE LTD-5.61%370
ARVIDA GROUP LTD--.--%361